Daewon Pharmaceutical Statistics
Total Valuation
KRX:003220 has a market cap or net worth of KRW 164.61 billion. The enterprise value is 307.07 billion.
Important Dates
The last earnings date was Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:003220 has 21.43 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 21.43M |
| Shares Outstanding | 21.43M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 38.80% |
| Owned by Institutions (%) | 11.47% |
| Float | 12.98M |
Valuation Ratios
The trailing PE ratio is 12.94 and the forward PE ratio is 7.98.
| PE Ratio | 12.94 |
| Forward PE | 7.98 |
| PS Ratio | 0.27 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | 7.84 |
| P/OCF Ratio | 3.82 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 9.08, with an EV/FCF ratio of 14.63.
| EV / Earnings | 23.21 |
| EV / Sales | 0.50 |
| EV / EBITDA | 9.08 |
| EV / EBIT | 34.87 |
| EV / FCF | 14.63 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.02 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 5.90 |
| Debt / FCF | 8.88 |
| Interest Coverage | 1.01 |
Financial Efficiency
Return on equity (ROE) is 4.88% and return on invested capital (ROIC) is 1.61%.
| Return on Equity (ROE) | 4.88% |
| Return on Assets (ROA) | 2.24% |
| Return on Invested Capital (ROIC) | 1.61% |
| Return on Capital Employed (ROCE) | 1.92% |
| Weighted Average Cost of Capital (WACC) | 3.56% |
| Revenue Per Employee | 493.55M |
| Profits Per Employee | 10.71M |
| Employee Count | 1,236 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 3.11 |
Taxes
| Income Tax | -813.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.28% in the last 52 weeks. The beta is 0.04, so KRX:003220's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -40.28% |
| 50-Day Moving Average | 7,903.40 |
| 200-Day Moving Average | 9,101.65 |
| Relative Strength Index (RSI) | 43.82 |
| Average Volume (20 Days) | 248,986 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003220 had revenue of KRW 610.02 billion and earned 13.23 billion in profits. Earnings per share was 593.58.
| Revenue | 610.02B |
| Gross Profit | 281.40B |
| Operating Income | 6.55B |
| Pretax Income | 12.18B |
| Net Income | 13.23B |
| EBITDA | 31.57B |
| EBIT | 6.55B |
| Earnings Per Share (EPS) | 593.58 |
Full Income Statement Balance Sheet
The company has 51.11 billion in cash and 186.37 billion in debt, with a net cash position of -135.27 billion or -6,310.99 per share.
| Cash & Cash Equivalents | 51.11B |
| Total Debt | 186.37B |
| Net Cash | -135.27B |
| Net Cash Per Share | -6,310.99 |
| Equity (Book Value) | 268.35B |
| Book Value Per Share | 12,186.11 |
| Working Capital | 3.56B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 43.14 billion and capital expenditures -22.14 billion, giving a free cash flow of 20.99 billion.
| Operating Cash Flow | 43.14B |
| Capital Expenditures | -22.14B |
| Depreciation & Amortization | 25.02B |
| Net Borrowing | -31.43B |
| Free Cash Flow | 20.99B |
| FCF Per Share | 979.49 |
Full Cash Flow Statement Margins
Gross margin is 46.13%, with operating and profit margins of 1.07% and 2.17%.
| Gross Margin | 46.13% |
| Operating Margin | 1.07% |
| Pretax Margin | 2.00% |
| Profit Margin | 2.17% |
| EBITDA Margin | 5.18% |
| EBIT Margin | 1.07% |
| FCF Margin | 3.44% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 3.26%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 3.26% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 40.50% |
| FCF Payout Ratio | 25.52% |
| Buyback Yield | -0.16% |
| Shareholder Yield | 3.10% |
| Earnings Yield | 7.73% |
| FCF Yield | 12.75% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for KRX:003220 is 13,000.00, which is 69.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 13,000.00 |
| Price Target Difference | 69.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 5.36% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Mar 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:003220 has an Altman Z-Score of 2.15 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 7 |